ALIVUSNSEAlivus Life Sciences Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 2 Apr, 2025 · 16:39 IST

Alivus Life Sciences Limited has informed the Exchange about Acquisition

Listed Co AcquisitionStrategic Transactions View source PDFExplain this filing

ALIVUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.5%Reaction day
₹1060.50
prior close
₹1045.00
announcement price
After-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+1.0%-0.5% vs market
Pharmaceuticals peers, median of 147sector+2.3%-1.8% vs sector

On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and 1.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+3.1
10m
+3.1
15m
+3.2
30m
+4.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.5+1.0-0.5+2.3-1.8
Next day
-5.4-2.6-2.8-0.6-4.9
2d
-8.3-6.9-1.4-4.6-3.6
3d
-5.4-4.6-0.8-3.1-2.4
4d
-11.5-5.8-5.7-4.0-7.6
5d
-9.0-2.6-6.4-1.9-7.2
1w
-6.6+1.4-7.9+1.0-7.5
15d
+2.0+2.0-0.0+2.3-0.2
1m
+2.7+1.2+1.5+1.3+1.4
2m
-0.5+11.7-12.2+6.4-6.9
3m
-3.1+15.2-18.3+7.2-10.2
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alivus Life Sciences Limited has informed the stock exchange about an acquisition. The company has made a regulatory disclosure notifying exchanges of this corporate action. Further details regarding the target company, deal size, and consideration are not available in the headline. Alivus Life Sciences, a pharmaceutical company, is expanding its business through this acquisition move. Shareholders should await further details from the company regarding the specifics of the deal.

Likely market impact

This acquisition could lead to business expansion and potentially impact the stock price depending on the deal size and strategic fit. Investors should watch for further disclosures about the target, deal value, and funding arrangement.